Time Restricted Eating and Innate Immunity
SIGNATURE
Effect of Short Term Time Restricted Eating on Innate Immunity in Patients With Coronary Artery Disease
1 other identifier
interventional
23
1 country
1
Brief Summary
The goal of this cross over study is to investigate the effect of short term time restricted eating (TRE) on the innate immune system in patients with a history of myocardial infarction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2022
CompletedStudy Start
First participant enrolled
November 17, 2022
CompletedFirst Posted
Study publicly available on registry
December 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2024
CompletedMarch 27, 2024
November 1, 2023
1.2 years
October 16, 2022
March 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change in the inflammatory phenotype of circulating immune cells, assessed by measuring the cytokine production capacity (e.g. IL-1b and TNF) of isolated PBMCs after ex vivo stimulation with various TLR ligands, determined by ELISA.
The investigators will measure the change in the inflammatory phenotype of circulating immune cells after TRE. Therefore, the investigators will assess the inflammatory phenotype at baseline and after a two week TRE period and a control period with a regular diet (cross-over design). This will be assessed by measuring the cytokine production capacity of isolated peripheral blood mononuclear cells (PBMCs) after ex vivo stimulation with various TLR ligands. Relevant cytokines (e.g. IL-1b and TNF, given in pg/ml) are measured in the supernatants of the PMBC stimulation experiments by ELISA.
Change from baseline cytokine production capacity at 2 weeks after TRE or regular diet.
Study Arms (2)
First TRE, then regular diet
OTHERThis group will start with 2 weeks TRE and will switch to the 2 week period of consuming their regular diet after a wash-out period.
First regular diet, then TRE
OTHERThis group will start with the 2 week period of consuming their regular diet and will switch to 2 weeks TRE after a wash-out period.
Interventions
Participants have to consume their regular food intake during a 6 hour period per day for 2 weeks.
Participants have to consume their regular diet within an unrestricted time period for 2 weeks
Eligibility Criteria
You may qualify if:
- Adult (age \>18 years)
- Diagnosed with a myocardial infarction (between 1 and 5 years ago)
- Body mass index between 20 and 35 kg/m2
- Able to understand, be motivated and follow the study related procedures
- Able to understand and give written informed consent
You may not qualify if:
- Myocardial infarction (defined as an increase in cardiac enzymes in combination with symptoms of ischemia or newly developed ischemic ECG changes), coronary artery bypass graft surgery or other major (cardiovascular) surgery, stroke or transient ischemic attack (TIA) in the past 1 year prior to screening.
- Use of immunomodulatory drugs
- Use of drugs that need to be taken with food.
- Diabetes Mellitus type I and type II
- Medical history of any disease associated with immune deficiency (either congenital or acquired, including chemotherapy, active malignancy, organ transplant) or auto immune disease
- Clinically significant infections within 1 months prior to start of or during intervention period or control period (defined as fever \>38.5).
- Vaccination \<1 month before start of or during intervention or control period.
- Eating disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Radboud University Medical Centerlead
- Dutch Heart Foundationcollaborator
Study Sites (1)
Radboud university medical center
Nijmegen, Gelderland, 6500 GB, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Niels P. Riksen, Prof. Dr.
Radboud University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2022
First Posted
December 6, 2022
Study Start
November 17, 2022
Primary Completion
January 25, 2024
Study Completion
January 25, 2024
Last Updated
March 27, 2024
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- All data from the research project will be shared after the publication of the results.
- Access Criteria
- All data will be made available without restrictions.
Data will be published in a data repository or other online data archive (e.g. DANS EASY, Radboud Data Repository, disciplinary repository, data archive). Data that is applicable for sharing (regarding privacy) will be published.